check_circleStudy Completed
Chronic Bronchitis
Bayer Identifier:
12629
ClinicalTrials.gov Identifier:
EudraCT Number:
Not Available
EU CT Number:
Not Available
SYMPROVE III: Health Services Research Study for Treatment of the Moderate and Severe Acute Exacerbations of Chronic Bronchitis (AECB)
Trial purpose
In this study data of patients with moderate or severe acute exacerbations of chronic bronchitis (AECB) were collected. There were two different cohorts which were compared (Moxifloxacin and other antibiotics) concerning effectiveness and tolerance. It was a prospective study which was accomplished in 100 ambulatory practice offices.
Key Participants Requirements
Sex
BothAge
18 - N/ATrial summary
Enrollment Goal
345Trial Dates
December 2009 - August 2010Phase
N/ACould I Receive a placebo
NoProducts
Avelox (Moxifloxacin hydrochloride, BAY12-8039)Accepts Healthy Volunteer
NoWhere to participate
Status | Institution | Location |
---|---|---|
Completed | Many Locations, Germany |
Primary Outcome
- Effectiveness and tolerance of/to the different therapiesdate_rangeTime Frame:within the first 14 daysenhanced_encryptionYesSafety Issue:
- Possible hospitalisation ratedate_rangeTime Frame:within the first 14 daysenhanced_encryptionYesSafety Issue:
Trial design
Trial Type
ObservationalIntervention Type
DrugTrial Purpose
N/AAllocation
N/ABlinding
N/AAssignment
N/ATrial Arms
N/A